NASDAQ: BLLN · Industrial Applications and Services · 13 alerts · CIK 2070849
Share price
$96.31Close, Nov 16
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BillionToOne, Inc. filings on SEC EDGAR ↗
BillionToOne SVP of Laboratory Operations Bosch John Roderick ten Sells $321K of Stock
Bosch John Roderick ten, SVP of Laboratory Operations, sold 2,834 shares of BillionToOne, Inc. at $113.17 a share, worth $321K in total on Nov 2, 2026. Shares held after the trade: 16,551 (-7.9%).
BillionToOne Chairman and CEO Oguzhan Atay Sells $3.33M of Stock
Oguzhan Atay, Chairman and CEO, sold 30,335 shares of BillionToOne, Inc. at $107.31 to $113.17 a share (average $109.93) in 14 transactions, worth $3.33M in total on Nov 2, 2026. Shares held after the trade: 141,167 (-1.9%).
David Tsao, CTO, sold 19,977 shares of BillionToOne, Inc. at $107.31 to $113.17 a share (average $109.24) in 13 transactions, worth $2.18M in total on Nov 2, 2026. Shares held after the trade: 1,023 (-16.9%).
BillionToOne, Inc. reported significant growth for the nine months ended September 30, 2026, with revenue increasing to $340.8 million from $209.1 million in the prior year. The company achieved a net income of $43.4 million for the first nine months of 2026, a substantial improvement compared to $1.5 million in the same period of 2025.
BillionToOne reported Q3 2026 revenue of $123.0 million, a 47% increase year-over-year, driven by strong growth in both prenatal and oncology clinical testing. The company maintained GAAP profitability with $11.0 million in operating income and raised its full-year 2026 revenue guidance to a range of $460 million to $470 million.
Term
Q3 2026
“Our third quarter was another period of strong execution. We delivered rapid growth with continued GAAP profitability, and more clinicians are choosing our tests in both prenatal and oncology.”
BillionToOne Chairman and CEO Oguzhan Atay Sells $1.3M of Stock
Oguzhan Atay, Chairman and CEO, sold 11,000 shares of BillionToOne, Inc. at $118.00 a share, worth $1.3M in total on Oct 28, 2026. Shares held after the trade: 146,501 (-1.8%).